On This episode of Stock Movers:

- Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly.

- Ryanair was fined more than €255 million ($300 million) by Italy’s antitrust watchdog for allegedly using an “abusive strategy” to thwart third-party travel agencies.

- Cevian Capital raises its total holding in Akzo Nobel NV to 10.15% from ~5%, according to a filing with the Dutch financial authority AFM.

On This episode of Stock Movers:
- Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly.
- Ryanair was fined more than &euro;255 million ($300 million) by Italy&rsquo;s antitrust watchdog for allegedly using an &ldquo;abusive strategy&rdquo; to thwart third-party travel agencies.
- Cevian Capital raises its total holding in Akzo Nobel NV to 10.15% from ~5%, according to a filing with the Dutch financial authority AFM.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Novo Nordisk's Pill, Ryanair Fined, Akzonobel's Activist

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/71c43d02-8250-468d-ac3c-b3bc00a5cf02/transcript

On this episode of Stock Movers:

- Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term.

- Shares of naval shipmaker Huntington Ingalls (HII) rallied ahead of the US market open after President Trump announced the Navy will build a new “Trump-class” battleship as part of the White House push to modernize a fleet that’s been hobbled by years of cost overruns and delays.

- Shares of Warner Bros. Discovery (WBD) edged higher in the early session as Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.’s bid for WBD, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix Inc.

On this episode of Stock Movers:
- Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly &amp; Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term.
- Shares of naval shipmaker Huntington Ingalls (HII) rallied ahead of the US market open after President Trump announced the Navy will build a new &ldquo;Trump-class&rdquo; battleship as part of the White House push to modernize a fleet that&rsquo;s been hobbled by years of cost overruns and delays.
- Shares of Warner Bros. Discovery (WBD) edged higher in the early session as Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.&rsquo;s bid for WBD, aiming to give his son&rsquo;s company an advantage in a fiercely contested takeover battle with Netflix Inc.

Novo Soars on Obesity Pill Approval; Huntington Ingalls Rallies; Warner Bros

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/304ce6a7-84f0-42fd-ad39-b3bc00c819c7/transcript

On This episode of Stock Movers:

- Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly.

- Orsted said it’s considering “all options” including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according to a statement late Monday.

- Pets at Home Group named James Bailey, the former managing director of upmarket grocer Waitrose, as its new chief executive officer to lead a reboot of the struggling pet care company. 

On This episode of Stock Movers:
- Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly.
- Orsted said it&rsquo;s considering &ldquo;all options&rdquo; including legal action as it weighs how to respond to a US decision to suspend leases for five offshore wind farms, according to a statement late Monday.
- Pets at Home Group named James Bailey, the former managing director of upmarket grocer Waitrose, as its new chief executive officer to lead a reboot of the struggling pet care company.&nbsp;

Novo Nordisk's Pill, Orsted Winded, Pets At Home Up

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ac303039-0a3c-45c5-a322-b3bc00962835/transcript

On this episode of Stock Movers: 
- Warner Bros. Discovery (WBD) shares rallied in trading today after word that Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.’s bid for it, aiming to give his son’s company an advantage in a fiercely contested takeover battle with Netflix. Paramount has been aggressively pursuing Warner Bros. for months and Ellison was taken by surprise when the board agreed to a deal with Netflix for $82.7 billion for the streaming and studio assets. The strength of the financing for each bid has emerged as a decisive issue in the takeover battle, which unleashed two massive debt-fueled offers that rank among the largest in the past decade. Paramount took its offer of $30 a share, or $108.4 billion including debt, for the entire company directly to shareholders. Warner Bros. shares gained 3.4% in New York afternoon trading, and changed hands during the session for as much as $28.98. Paramount rose as much as 8.1% while Netflix dropped about 1%. 
- First Solar (FSLR) rose as much as 7.1%, touching the highest intraday since June 2024, after news Alphabet will buy clean-energy developer Intersect Power in one of the company’s biggest deals aimed at boosting its AI-related data-center footprint. The stock was the top S&P 500 gainer with less than 10 minutes to the close. Other solar names with gains in Monday trading included: Canadian Solar up as much as 15%; Array Technologies rises as much as 10%; Nextpower +7.7%.
- Clearwater Analysts (CWAN) shares are up 8.5% on Monday, after a group of private equity firms agreed to buy the investment and accounting software company in a deal valuing it at $8.4 billion. Analysts said the deal price was lower than expected.

On this episode of Stock Movers: - Warner Bros. Discovery (WBD) shares rallied in trading today after word that Larry Ellison is throwing his personal fortune behind Paramount Skydance Corp.&rsquo;s bid for it, aiming to give his son&rsquo;s company an advantage in a fiercely contested takeover battle with Netflix. Paramount has been aggressively pursuing Warner Bros. for months and Ellison was taken by surprise when the board agreed to a deal with Netflix for $82.7 billion for the streaming and studio assets. The strength of the financing for each bid has emerged as a decisive issue in the takeover battle, which unleashed two massive debt-fueled offers that rank among the largest in the past decade. Paramount took its offer of $30 a share, or $108.4 billion including debt, for the entire company directly to shareholders. Warner Bros. shares gained 3.4% in New York afternoon trading, and changed hands during the session for as much as $28.98. Paramount rose as much as 8.1% while Netflix dropped about 1%. - First Solar (FSLR) rose as much as 7.1%, touching the highest intraday since June 2024, after news Alphabet will buy clean-energy developer Intersect Power in one of the company&rsquo;s biggest deals aimed at boosting its AI-related data-center footprint. The stock was the top S&amp;P 500 gainer with less than 10 minutes to the close. Other solar names with gains in Monday trading included: Canadian Solar up as much as 15%; Array Technologies rises as much as 10%; Nextpower +7.7%. - Clearwater Analysts (CWAN) shares are up 8.5% on Monday, after a group of private equity firms agreed to buy the investment and accounting software company in a deal valuing it at $8.4 billion. Analysts said the deal price was lower than expected.

Warner Bros. Discovery Rises, First Solar Rallies, Clear Water Moves Higher

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a9cec278-f541-49ae-acad-b3bb016bc452/transcript

Novo Nordisk's Pill, Ryanair Fined, Akzonobel's Activist

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips